Mirador Therapeutics
Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases
$250MSeries B
Role not disclosedLoading investors…
Activity from announced rounds
Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases
Pitching Adage Capital Partners L.P.? Send the deck from a free RoundOS data room and see which pages they read.